Several other research firms have also commented on ESRX. ValuEngine raised Express Scripts Holding from a hold rating to a buy rating in a report on Monday, October 2nd. Robert W. Baird reaffirmed a hold rating and set a $56.00 target price on shares of Express Scripts Holding in a report on Friday, September 1st. Needham & Company LLC assumed coverage on Express Scripts Holding in a report on Friday, July 21st. They set a hold rating for the company. BidaskClub lowered Express Scripts Holding from a sell rating to a strong sell rating in a report on Friday, August 4th. Finally, Raymond James Financial, Inc. reaffirmed an underperform rating on shares of Express Scripts Holding in a report on Monday, October 9th. Seven research analysts have rated the stock with a sell rating, ten have assigned a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of Hold and an average target price of $69.53.
Shares of Express Scripts Holding (ESRX) traded down $0.70 during midday trading on Wednesday, reaching $60.05. The company’s stock had a trading volume of 3,608,400 shares, compared to its average volume of 4,115,587. Express Scripts Holding has a 12-month low of $55.80 and a 12-month high of $77.50. The firm has a market capitalization of $34,407.16, a PE ratio of 8.88, a P/E/G ratio of 0.90 and a beta of 0.88. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.73 and a quick ratio of 0.61.
Express Scripts Holding (NASDAQ:ESRX) last announced its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.90. Express Scripts Holding had a return on equity of 25.46% and a net margin of 3.64%. The firm had revenue of $24.68 billion for the quarter, compared to analysts’ expectations of $25.68 billion. During the same quarter in the prior year, the firm posted $1.74 earnings per share. Express Scripts Holding’s revenue for the quarter was down 2.9% compared to the same quarter last year. research analysts anticipate that Express Scripts Holding will post 7.01 EPS for the current fiscal year.
In related news, VP Everett Neville sold 1,163 shares of the stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $61.48, for a total transaction of $71,501.24. Following the completion of the sale, the vice president now directly owns 18,232 shares in the company, valued at $1,120,903.36. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, VP Phyllis S. Anderson sold 578 shares of the stock in a transaction on Friday, September 8th. The stock was sold at an average price of $63.13, for a total value of $36,489.14. Following the sale, the vice president now owns 10,530 shares of the company’s stock, valued at $664,758.90. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 6,284 shares of company stock valued at $397,421. 0.68% of the stock is owned by corporate insiders.
A number of institutional investors have recently bought and sold shares of the business. Zeke Capital Advisors LLC increased its position in Express Scripts Holding by 85.4% during the third quarter. Zeke Capital Advisors LLC now owns 12,347 shares of the company’s stock worth $782,000 after buying an additional 5,688 shares during the last quarter. Twin Capital Management Inc. increased its position in Express Scripts Holding by 79.5% during the third quarter. Twin Capital Management Inc. now owns 83,207 shares of the company’s stock worth $5,269,000 after buying an additional 36,857 shares during the last quarter. Cadence Capital Management LLC acquired a new position in Express Scripts Holding during the third quarter worth $1,550,000. Marshall & Sullivan Inc. WA increased its position in Express Scripts Holding by 4.1% during the third quarter. Marshall & Sullivan Inc. WA now owns 41,102 shares of the company’s stock worth $2,519,000 after buying an additional 1,615 shares during the last quarter. Finally, Schroder Investment Management Group increased its position in Express Scripts Holding by 12.1% during the third quarter. Schroder Investment Management Group now owns 2,314,162 shares of the company’s stock worth $145,954,000 after buying an additional 248,883 shares during the last quarter. 90.30% of the stock is currently owned by hedge funds and other institutional investors.
Express Scripts Holding Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.